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A B S T R A C T
Oxidative stress and mitochondrial dysfunction are critical events in neurodegenerative diseases; therefore,
molecules that increase cellular antioxidant defenses represent a future pharmacologic strategy to counteract
such conditions. The aim of this study was to investigate the potential protective effect of (PhSe)2 on mouse
hippocampal cell line (HT22) exposed to tert-BuOOH (in vitro model of oxidative stress), as well as to elucidate
potential mechanisms underlying this protection. Our results showed that tert-BuOOH caused time- and con-
centration-dependent cytotoxicity, which was preceded by increased oxidants production and mitochondrial
dysfunction. (PhSe)2 pre-incubation significantly prevented these cytotoxic events and the observed protective
effects were paralleled by the upregulation of the cellular glutathione-dependent antioxidant system: (PhSe)2
increased GSH levels (> 60%), GPx activity (6.9-fold) and the mRNA expression of antioxidant enzymes Gpx1
(3.9-fold) and Gclc (2.3-fold). Of note, the cytoprotective effect of (PhSe)2 was significantly decreased when cells
were treated with mercaptosuccinic acid, an inhibitor of GPx, indicating the involvement of GPx modulation in
the observed protective effect. In summary, the present findings bring out a new action mechanism concerning
the antioxidant properties of (PhSe)2. The observed upregulation of the glutathione-dependent antioxidant
system represents a future pharmacologic possibility that goes beyond the well-known thiol-peroxidase activity
of this compound.
1. Introduction
Neurodegenerative diseases, including Alzheimer's disease,
Parkinson's disease and amyotrophic lateral sclerosis, differ widely in
their pathology and symptoms. However, they share common events
that can mediate the neurodegeneration observed in these conditions.
Because neurons are highly demanding energy cells that rely on the
mitochondrial integrity to support this bioenergetic demand [1], mi-
tochondrial dyshomeostasis represent one of the mentioned common
events mediating the neuronal damage characteristic of different neu-
rodegenerative diseases [2].
The brain is particularly vulnerable to oxidative stress because of its
high metabolic rate and relatively low antioxidant defense capability
[3]. Because the brain is rich in lipids containing polyunsaturated fatty
acids (PUFAs), lipid peroxidation is the prominent type of oxidative
damage [4]. In this context, glutathione peroxidases (GPxs), which
catalyze the reduction of H2O2 or organic hydroperoxides to water or
the corresponding alcohols, respectively, typically using glutathione
(GSH) as reductant, play a critical role in the control of oxidative stress
in the brain [5]. Particularly, GPx1, which is present in both neurons
and glial cells [6], is ubiquitously found in the cytosol and mitochon-
dria of cells, working in the water phase. GPx4 is a plasma and
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mitochondria membrane-associated enzyme, where it catalyzes the re-
duction of lipid hydroperoxides [5,7]. Moreover, overexpression of GPx
decreases neuronal cell death and reduces hydrogen peroxide accu-
mulation and the consequent lipid peroxidation under neurotoxic
conditions [8].
Taking into account the aforementioned, strategies to counteract
harmful cellular oxidative events and preserve mitochondrial integrity
by increasing cellular antioxidant defenses are emerging as promising
therapeutic approaches to prevent neuronal damage. In this scenarium,
various organoselenium compounds have been synthesized and studied
over the years aiming to mimic the peroxidase activity of the GPx,
however the biological properties of organoselenium compounds are
much more complex and seem to go far beyond their GPx mimetic
activity [9]. Of particular importance, our group and others are dedi-
cated to evaluating the antioxidant properties of the simple diaryldi-
selenide, diphenyl diselenide (PhSe)2. Pharmacological properties of
(PhSe)2 has been described in experimental models of central nervous
system (CNS) pathologies, including Parkinson's disease [10], Alzhei-
mer's disease [11], methylmercury-induced neurotoxicity [12], and as
antidepressive therapy [13]. Some in vitro studies were performed to
evaluate the mechanisms involved in the cytoprotective effect of
(PhSe)2 against different oxidative stress conditions. (PhSe)₂ prevented
the endothelial and mitochondrial dysfunction induced by peroxynitrite
through enhancing cellular antioxidant defenses [14,15]. Moreover,
this simple organoselenium compound protected macrophages, against
the oxLDL cytotoxic effects by reducing the oxidants production, which
in turn prevented the nuclear factor NF-κB activation [16].
As already mentioned, specific organoselenium compounds have
been synthesized to mimic the peroxidase activity of the GPx and
therefore protect against oxidative stress-related conditions [17].
However, the simple thiol-peroxidase activity of these compounds seem
to be not enough to justify their antioxidant properties in biological
systems [17,18]. In this study, we aimed to evaluate the beneficial ef-
fects of (PhSe)2 against oxidative changes promoted by tert-BuOOH in
the HT22 neuronal cell line. The hippocampal neuronal cell line HT22
has been used to unravel mechanistic aspects associated with hippo-
campal damage and potential therapeutic strategies in neurodegen-
erative diseases [19] while tert-Butyl hydroperoxide (tert-BuOOH) has
been widely used to induce oxidative stress and mitochondrial dys-
function in a variety of cell types including HT22 cell [20]. Our data
indicate that (PhSe)2 was effective in preventing tert-BuOOH-induced
oxidants production and mitochondrial dysfunction by modulating the
glutathione-dependent antioxidant system, particularly the GPx1.
2. Material and methods
2.1. Reagents
β-Nicotinamide adenine dinucleotide phosphate sodium salt re-
duced (NADPH), dimethyl sulfoxide (DMSO), glutathione reductase
from baker's yeast, reduced glutathione, 3-(4,5-dimethylthiazol- 2-yl)-
2,5-diphenyltetrazolium bromide (MTT), propidium iodide (PI), 2′,7′-
dichlorofluorescein diacetate (DCFH2-DA), 5,5′-dithiobis-(2- ni-
trobenzoic-acid) (DTNB), tert-butyl hydroperoxide (tBuOOH), mercap-
tosuccinic acid (MS), proton ionophore carbonyl cyanide 4-(tri-
fluoromethoxy) phenylhydrazone (FCCP), antimycin A and oligomycin
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's
Modified Eagle's Medium (DMEM) and fetal bovine serum (FBS) were
obtained from Gibco Life Technologies (Carlsbad, CA). MitoSOX™ Red
probe was obtained from Invitrogen (USA). RQ1 RNase-Free DNase,
GoScript™ Reverse Transcription System and GoTaq qPCR Master Mix
were purchased from Promega Corporation (USA). All other chemicals
were of the highest grade available commercially.
2.2. Cell culture
The HT22 cells, an immortalized mouse hippocampal neuronal cell
line, were a gift from Dr. David Schubert (Salk Institute, La Jolla, CA,
USA). HT22 cells were maintained in DMEM supplemented with 5% (v/
v) fetal bovine serum (FBS; Gibco/lnvitrogen), 2 mM glutamine, 100
units/mL penicillin, 100 μg/mL streptomycin, 10mM Hepes, 24mM
glucose, 44mM NaHCO3 and incubated at 37 °C in a humidified at-
mosphere of 5% CO2. Cells were subcultured at confluences of 80–90%,
and used between the 3rd and 12th passages. Cell suspensions were
seeded in dish plates (100×20mm), 96-, or 6-well plaques at different
cell densities, depending on the experimental procedure, as described
below.
2.3. Cell viability assays
Cell viability was measured by two different assays: MTT reduction
and PI uptake. For these assays, cells were plated into 96-well plates at
a cell density of 1× 103 cells/well and cultivated for 24 h. In order to
determine the tBuOOH toxicity, HT22 cells were incubated with 0.05%
DMSO (used as vehicle in further experiments) and maintained in cul-
ture for additional 48 h. Then, cells were exposed to tBuOOH (10, 20,
40, 70 and 100 μM) for 12 h; - to determine the timeline of tBuOOH
toxicity, cells were incubated with tBuOOH (40 μM) for 2, 4, 5, 6, 7, 9
and 12 h. In parallel experiments, cells were incubated with (PhSe)2
(0.5, 1, 3, 6 and 10 μM) for 48 h in order to evaluate the concentration-
response effect of (PhSe)2 per se; – to evaluate the protective effect of
(PhSe)2, cells were pre-incubated with nontoxic concentration of
(PhSe)2 (0.5, 1, 2 and 5 μM) or vehicle (DMSO, 0.05%) during 48 h.
Afterward, the medium was replaced by a fresh medium and cells were
exposed to tBuOOH (40 μM) for 12 h. To establish potential mechan-
isms involved in the cytoprotective effect of (PhSe)2, cells were pre-
treated with (PhSe)2 (2 μM) or vehicle (DMSO, 0.05%) during 48 h and
then 5mM mercaptosuccinic acid (MS; inhibitor the GPx activity) was
added 30min before the exposure to tBuOOH (40, 70 and 100 μM) for
additional 12 h. tBuOOH was diluted in water and always prepared at
the time of use. The reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyl-tetrazolium bromide (MTT) to the formazan product by mi-
tochondrial dehydrogenases in viable cells was conducted as described
by Mosmann [27]. Propidium iodide (PI), which is excluded by living
cells but rapidly enters cells with damaged membranes and binds to
DNA, rendering them brightly fluorescent, was measured according to
Riccardi and Nicoletti [28]. Results of MTT assays were expressed as
percentage of untreated cells and the results of PI uptake assays were
expressed as percentage of 2% Triton X-100-treated cells that represent
the 100% of death. All experiments were performed in triplicate and
read on a spectraMax Paradigm spectrofluorometer (Molecular De-
vices).
2.4. Measurement of oxidants production
Intracellular oxidants production was detected using the 2′,7′- di-
chlorodihydrofluorescein diacetate (DCFH2-DA) and mitochondrial su-
peroxide radical generation was measured using MitoSOX probe. HT22
cells (1× 103 cells/well) were plated into 96-well plates for 24 h and
then pre-incubated with (PhSe)2 (2 μM) or vehicle (DMSO, 0.05%) for
48 h. Afterward, DCFH2-DA (1 μM) was added to the culture medium
and incubated for 30min, at 37 °C in a humidified atmosphere of 5%
CO2. In parallel, MitoSOX (5 μM) was dissolved in medium HBSS and
was added in HT22 cells pre-incubated with (PhSe)2, and incubated for
15min at 37 °C. In both experiments, the medium was removed and
fresh Hanks’ balanced salt solution (HBSS) was added, and then cells
were treated with tBuOOH (40, 70 and 100 μM). The fluorescence of
DCF (485 nm excitation and 520 nm emission) inside the cells was
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immediately measured after tBuOOH addition (during 2 h at each
10min) and used to evaluate the oxidants production. Results were
expressed as Area Under the Curve (A.U.C) and compared to the control
(vehicle). The fluorescence of MitoSOX (510 nm excitation and 580 nm
emission) was immediately measured after tBuOOH (40, 70 and
100 μM) addition (in 4 h) and the results were expressed as percentage
of untreated cells. All experiment were performed in triplicate and read
on a spectraMax Paradigm spectrofluorometer (Molecular Devices).
2.5. High-resolution respirometry of intact cells
To evaluate the mitochondrial oxygen consumption, HT22 cells
(3× 105 cells/plate) were plated into Petri plates for 24 h. After, cells
were pre-incubated with (PhSe)2 (2 μM) or vehicle for 48 h followed by
tBuOOH (40 μM) exposure for 2 h or 4 h. Approximately one million
suspended cells (in DMEM 5% FBS) were charged in OROBOROS
Oxygraph-2k chambers under continuous stirring at 750 r.p.m. at 37 °C.
After stabilization of the signal, basal oxygen consumption rates (OCR)
was recorded, which is defined as respiration with the physiological
substrates in growth medium. ATP synthase was inhibited with oligo-
mycin (1.25 μM) and uncoupled OCR was recorded. Then, the proton
ionophore carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP, uncoupler of oxidative phosphorylation) was used in 0.5 μM
steps to determination the maximum OCR or maximum respiratory
capacity. Respiration was inhibited by application of 2.5 μM antimycin
A to determine the non-mitochondrial OCR (residual oxygen con-
sumption – ROX). DatLab software (Oroboros Instruments) was used for
data acquisition and analysis. The difference in OCR was compared
with the control group (vehicle).
2.6. Assessment of glutathione peroxidase (GPx) activity
HT22 cells (1× 105 cells/well) were seeded for 24 h in 6-well plates
and pre-incubated with (PhSe)2 (2 μM) or vehicle (DMSO, 0.05%) for
additional 48 h. In another experimental set, cells were pre-incubated
with (PhSe)2 (2 μM) or vehicle (DMSO, 0.05%) for 43 h and then ex-
posed to Mercaptosuccinic acid (MS; 5mM) for additional 12 h. After
treatments, the medium was aspirated and the cells were washed once
with phosphate-buffered saline (PBS), trypsinized and suspended (1:1
ratio) in DMEM 5% FBS. Cell suspension were centrifuged at 500×g for
2min at room temperature and the cell pellets were stored at − 80 °C
until assay. For GPx assay, cell pellets were suspended in 50 μL of buffer
(20mM TrisHCl, 0.25M sucrose; containing 0.4 mM β-mercap-
toethanol) at pH 7.4 on ice. The samples were sonicated for 5min (three
times) on ice with vortex of 20 s to each sonicate time, and centrifuged
at 10,000×g for 15min at 4 °C. The supernatant was collected and used
for kinetic GPx activity assay (10 μL/well). GPx activity was performed
by measuring the consumption of NADPH at 340 nm [21] and opti-
mized conditions for HT22 cell lysate described by Panee et al. [22].
The following reagents and concentrations were used: tert-butyl hy-
droperoxide (0.32mM), GSH (1.88mM), GR (84mU/mL), EDTA
(1mM), NaN3 (1mM), NADPH (0.2 mM) and Tris-HCl pH 7.6 (0.1M).
The experiments were performed in triplicate and read on a spectraMax
Paradigm Multi-Mode Microplate Reader (Molecular Devices). The re-
sults were expressed as nmol NADPH consumed per min per milligram
of protein.
2.7. Determination of glutathione (GSH) and nonproteic thiols (NPSH)
content
GSH and NPSH content were determined using a fluorimetric assay
described by Hissin and Hilf [23] and a spectrophotometric assay as
described by Ellman [24], respectively. HT22 cells (1× 105 cells/well)
were seeded for 24 h in 6-well plates and incubated with (PhSe)2 (2 μM)
or vehicle (DMSO, 0.05%) for 48 h. Then, cells were harvested in 150 μL
of PBS buffer (0.05% Triton X-100, pH 7.4) and mixed in a
trichloroacetic acid 10% solution. After centrifugation (5000×g at 4 °C
for 10min), supernatant was used to determined GSH and NPSH con-
tent. A volume of 30 μL of supernatant was incubated with 10 μL of
ortho-phthalaldehyde (0.1% w/v in methanol) and 160 μL of 100mM
Na2HPO4 for 15min at room temperature to fluorimetric assay. A vo-
lume of 50 μL of supernatant was incubated with 25 μL of DTNB
(10mM) and 125 μL of potassium phosphate buffer (1M) for 15min at
room temperature to spectrophotometry assay. Fluorescence intensity
(350 nm excitation and 420 nm emission) and spectrophotometry (ab-
sorbance 412 nm) assay were read on a spectraMax Paradigm Multi-
Mode Microplate Reader (Molecular Devices). Cellular GSH and NPSH
contents were calculated by using concurrently run standard curve of
GSH. The results were expressed as nmol GSH per milligram of protein
or percent of control group (vehicle).
2.8. Protein quantification
Protein quantification was performed by Lowry method [25], using
bovine serum albumin as standard.
2.9. Transcript level of antioxidant enzymes by RT-qPCR
To evaluate the transcript level of Gpx1, γ-glutamylcysteine synthe-
thase (Gclc), Gpx4, heme oxygenase-1 (HO-1), catalase (Cat), superoxide
dismutase-2 (Sod2), thioredoxin reductase 2 (Txnrd2), and peroxiredoxins
isoforms (Prdx2, Prdx3 and Prdx5), HT22 cells (1× 105 cells/well) were
seeded in 6-well plates and cultivated for 24 h. Then, cells were in-
cubated with (PhSe)2 (2 μM) or vehicle (DMSO, 0.05%) during 30 h.
Total RNA was extracted in different times of incubation (3 h, 6 h, 12 h,
24 h and 30 h) using Tri-reagent (Sigma-Aldrich) according to the
manufacturer's instructions. DNA contamination of samples was re-
moved by treatment with RQ1 RNase-Free DNase (Promega) at 25 °C for
1 h. After, RNA samples (90 μL) were precipitated with 10 μL acetate
sodium (3M) and 100 μL of isopropyl alcohol at room temperature for
10min. After the centrifugation at 12,000×g for 10min, the pellet was
washed with 70% ethanol and centrifuged at 12,000×g for 10min. PCR
of β-act gene was realized for verify the effectiveness of DNase treat-
ment. RNA concentrations and quality were determined using spec-
trophotometry (BIO-5000-BI/ KASUAKI). RNA samples with A260/280
and A260/230 absorbance ratio> 1.8 were considered acceptable for
cDNA synthesis. The integrity of total RNA was determined by 1.5%
agarose gel electrophoresis. For cDNA synthesis, GoScript™ Reverse
Transcription System (Promega) were used according to the manufac-
turer's instructions. The reaction (20 μL) consisted of 1 µg of total RNA,
Oligo(dT)15 primer (0.25 µg), 4 μL of GoScript 5X Reaction Buffer,
GoScript Reverse Transcriptase (160 U, Promega), 0.5mM of each
dNTP, 2.5 mM MgCl2, and ribonuclease inhibitor (20 U). First, RNA
samples and Oligo(dT)15 were mixed, incubated at 70 °C for 5min and
immediately placed on ice for 5min. After, other mentioned above
components were added and runs at 25 °C for 5min, 42 °C for 60min,
and 70 °C for 15min.
Real time PCR was carried out in 96-well plates using the 7900HT
Fast Real-Time PCR System (Applied Biosystems), and was performed
with GoTaq qPCR Master Mix (Promega). Sequences of primers of the
genes are indicated in the Table 1. The qPCR reaction (10 μL) consisted
of 1 μL of 10-fold diluted cDNA, 0.3 μL of each primer (10 µM), 5 μL of
master mix (2X), 0.1 μL of CXR and 3.3 μL DEPC-water. The thermal
cycling program was as follows: 50 °C for 2min, 95 °C for 10min, 40
amplification cycles of 95 °C for 15 s and 60 °C or 62 °C for 1min, and a
melting curve analysis at 95 °C for 15 s, 60 °C for 15 s, and 95 °C for 15 s.
Each sample was analyzed in technical duplicate. The amplification
efficiency (E) was calculated according to the equation E=10(1/−slope)
from a standard curve of five-fold serial dilutions (1/10, 1/20, 1/40, 1/
80, 1/160) of pooled cDNA. Efficiency of 1.9–2.1 and Pearson's coef-
ficients of determination (R2) of each gene> 0.99 were considered for
RT-qPCR. β-act gene was used to normalize the transcript levels of
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genes, and calculated by the 2-ΔΔCT method [26]. To determine the
copies number of Gpx4, a ten-fold series dilution (108 to 104 copies) of
pGEM-T plasmid carrying the fragment of mtGpx4 (mitochondrial
Gpx4) or cGpx4 (cytoplasmic Gpx4) or Gapdh was made and used as
standard curves for absolute quantification by qPCR [27].
2.10. Statistical analysis
Statistical analysis of the data was performed using the STATISTICA
software system, version 8.0. (StatSoft, Inc., 2008). Normal (Gaussian)
distribution and homogeneity of variance were evaluated with the
Kolmogorov–Smirnov test and Levene's test, respectively. Significant
differences were evaluated by Student's t-test, one-way, two-way or
three-way analysis of variance (ANOVA), depending on the experi-
mental design. Multiple comparisons were performed using the Tukey
post-hoc test. Results were expressed as mean ± SEM. p < 0.05 was
considered statistically significant. All graphics were made using the
GraphPad PRISM® software version 6.00 for Windows (GraphPad
Software, San Diego, CA, USA).
3. Results
3.1. tert-BuOOH induces toxicity in HT22 cells
The effect of tert-BuOOH exposure in HT22 cell viability was eval-
uated in time- and concentration-response experiments. The Fig. 1A and
B depict concentration-response studies after overnight exposure
(~ 12 h) of HT22 cells to tert-BuOOH (0–100 μM). The results show that
tert-BuOOH caused a significant decline in the MTT reduction starting
at 20 μM (Fig. 1A). In addition, tert-BuOOH induced a disruption in cell
plasma membrane (PI uptake) starting at 40 μM (Fig. 1B). Therefore,
the 40 μM tert-BuOOH concentration was used in the time-response
study (2–12 h). At this condition, the cells present a significant reduc-
tion in the ability to convert MTT to formazan starting 6 h after ex-
posures (Fig. 1C) and a significant disruption of the cellular plasma
membrane was verified after 9 h (increased PI uptake) (Fig. 1D). Based
on these results, it can be argued that cell viability and cell plasma
membrane integrity were not significantly affected within two or four
hours of exposure to tert-BuOOH (40 μM). Thus, these conditions were
chosen to investigate molecular mechanisms mediating the toxicity
induced by tert-BuOOH, as well as the potential protective effects of
(PhSe)2.
3.2. (PhSe)2 protects HT22 cells against tert-BuOOH-mediated toxicity
Firstly, to assess non-toxic concentrations of (PhSe)2, a concentra-
tion-response study was conducted by pre-incubating HT22 cells for
48 h with concentrations of (PhSe)2 ranging from 0.5 to 10 μM. As
shown in Fig. 2A-B, there was no significant decrease in cell viability
after 48 h of pre-incubation with (PhSe)2 at concentrations up to 6 μM.
Based on these results, the non-toxic concentrations of (PhSe)2 (1–5 μM)
were chosen to evaluate its protective effect against tert-BuOOH-
mediated cytotoxicity (Fig. 2A-B). Our results show that the pre-in-
cubation with 2 μM of (PhSe)2 for 48 h significantly protected HT22
cells against tert-BuOOH-induced decrease in MTT reduction (Fig. 2C)
and increase PI uptake (Fig. 2D).
3.3. (PhSe)2 prevents tert-BuOOH-induced oxidants production in HT22
cells
Taking into account that tert-BuOOH-mediated cell damage is
commonly related to oxidative stress, we investigated whether (PhSe)2
protects HT22 cells from tert-BuOOH-induced oxidants generation.
Oxidants-mediated DCFH2 oxidation was evaluated in HT22 cells
within the first 2 h after tert-BuOOH exposure (40, 70 and 100 μM). A
concentration-dependent increase in oxidants production was observed
after tert-BuOOH exposure (Fig. 3A-B). The pre-incubation with (PhSe)2
completely prevented the oxidants production in HT22 cells exposed to
tert-BuOOH (40 μΜ) (Fig. 3C) and partially prevented at higher tert-
BuOOH concentrations (70–100 μM) (Fig. 3D-E). Of note, oxidants
production was not changed in HT22 cells pre-incubated only with
(PhSe)2 (Fig. 3C-E). In accordance, our results using MitoSOX showed
Table 1
Primer sequences used for RT-qPCR experiments.




Gpx1 Glutathione peroxidase 1 CTCACCCGCTCTTTACCTTC 129 60 Quispe et al. [20]
CAAAGTTCCAGGCAATGTCG
mtGpx4 Mitochondrial glutathione peroxidase 4 CCGCCGAGATGAGCTGG 158 60 Casañas-Sánchez et al. [28];
Quispe et al. [20]GTCGATGTCCTTGGCTGAG
mcGpx4 Mitochondrial and cytosolic glutathione
peroxidase 4
GTCTGGCAGGCACCATGT 83 60 Quispe et al. [20]
GTCGATGTCCTTGGCTGAG
Gclc Glutamate-cysteine ligase catalytic
subunit
TTACCGAGGCTACGTGTCAGAC 200 62 Kurauchi et al. [29]
TGTCGATGGTCAGGTCGATGTC
HO-1 Heme oxygenase 1 CAGCCCCACCAAGTTCAAA 63 60 Tighe et al. [30]
TCAGGTGTCATCTCCAGAGTGTTC
Cat Catalase TGAAGCAGTGGAAGGAGCAG 156 62 This study
AGTGTGCCATCTCGTCAGTG
Sod2 Superoxide dismutase 2 GACCTGCCTTACGACTATG 108 60 This study
GGTGGCGTTGAGATTGTTC
Prdx2 Peroxiredoxin 2 CTTTTGTTTGCCCCACGGAG 244 62 This study
AGACCCCTGTAAGCAATGCC
Prdx3 Peroxiredoxin 3 AAGGCGTTCCAGTTTGTAG 88 60 This study
CTGTTGGACTTGGCTTGA
Prdx5 Peroxiredoxin 5 GTGGCCTGTCTGAGCGTTAA 170 60 This study
TTCAGCCGACGATTCCCAAA




138 60 Flowers et al. [31]
Gapdh Gliceraldehyde-3-phosphate
dehydrogenase
CATCACTGCCACCCAGAAGACTG 153 60 Know et al. [32]
ATGCCAGTGAGCTTCCCGTTCAG
AT: Annealing temperature.
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Fig. 1. tert-BuOOH induced toxicity in HT22
cells. HT22 cells were exposed to different tert-
BuOOH concentrations (10–100 μM) for ~ 12 h
(A, B) or to 40 μM for 2–12 h (C, D). Cell via-
bility was evaluated by MTT reduction (A, C)
and PI uptake (B, D). Results of MTT assay
were expressed as the percentage of MTT re-
duction with respect to control group. Results
of PI assays were expressed as the percent of PI
uptake-cell, where the 100% of cell death
value represents cells treated with 2% Triton
X-100 during 15min. Data were represented as
mean ± SEM (A,B; n= 6) (C, D; n=4).
* p < 0.05, *** p < 0.001 and **** p <
0.0001 indicate statistical difference from
control group by one-way ANOVA, followed by
the Tukey post hoc test.
Fig. 2. (PhSe)2 protects cells against tert-
BuOOH-mediated toxicity. (A-B) HT22 cells
were pre-incubated with different concentra-
tions of (PhSe)2 (0.5, 1, 3, 6 and 10 μM) for
48 h. Cell viability and PI uptake were eval-
uated by MTT reduction and PI uptake, re-
spectively. (C-D) Cells were pre-incubated with
non-toxic concentrations of (PhSe)2 (0.5; 1; 2
and 5 μM) for 48 h followed by exposure to
tert-BuOOH (40 μM) for additional 12 h. Cell
viability was evaluated by MTT reduction (A;
C) and cell death by PI uptake (B; D). Results of
MTT assay were expressed as the percentage of
MTT reduction with respect to control group.
Results of PI assays are expressed as percent of
PI uptake, where the 100% of cell death value
represent cells treated with 2% Triton X-100
during 15min. Data are represented as
mean ± SEM (A-B; n= 4, C-D; n=6).
* p < 0.05, ** p < 0.01, *** p < 0.001 in-
dicate statistical difference from control group
(dashed line) by one-way ANOVA followed by
the Tukey post hoc test.
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that the pre-incubation with (PhSe)2 (2 μM) for 48 h prevented the
peroxide-induced mitochondrial oxidants generation after 4 h of ex-
posure to tert-BuOOH concentrations (40–100 μM) (Fig. 3F).
3.4. (PhSe)2 prevents the mitochondrial dysfunction induced by tert-
BuOOH
Using high-resolution respirometry, the mitochondrial oxygen con-
sumption in intact HT22 cells was evaluated. The exposure of HT22
cells for 2 or 4 h to 40 μM tert-BuOOH, concentration which not affect
the cell viability (Fig. 1C-D), caused a significant decrease in several
mitochondrial oxygen consumption rates (OCR) (Fig. 4A). Already in a
short period of tert-BuOOH exposure (2 h), a significant decrease in the
maximal respiration rate and mitochondrial reserve capacity were ob-
served in HT22 cells pre-incubated with vehicle (DMSO, 0.05%) (black
bar) (Fig. 4B). Mitochondrial dysfunction was more evident after 4 h of
tert-BuOOH exposure (compared with 2 h exposure), characterized by a
decrease in the basal OCR, the ATP-linked oxygen consumption, the
maximum OCR and mitochondrial reserve capacity (black bar)
(Fig. 4C). The pre-incubation with 2 μM (PhSe)2 prevented the mi-
tochondrial dysfunction induced by tert-BuOOH in HT22 cells (Fig. 4).
3.5. (PhSe)2 modulates the glutathione-dependent antioxidant system in
HT22 cells
Results from Fig. 5A strongly suggested that (PhSe)2-treated cells
were more efficient to neutralize tert-BuOOH. The results show an in-
tense tert-BuOOH-induced decrease in cell viability since concentration
as 20 μM, while (PhSe)2-pre-incubated cells resist to the cell death in-
duced by tert-BuOOH even in high peroxide concentrations tested (20,
Fig. 3. (PhSe)2 prevents oxidants production induced by tert-BuOOH. (A) HT22 cells were exposed to tert-BuOOH followed by kinetic oxidation of DCFH2-DA (1 μM)
monitored for 2 h. Representative time course of oxidants production in HT22 cells exposed to different concentrations of tert-BuOOH (20, 40, 70 and 100 μM). (B)
The kinetic oxidation of DCFH2-DA (1 μM) was monitored for 2 h. Area under the curve (A. U. C) was calculated from the kinetic data shown in figure A. (C-F) HT22
cells were pre-incubated with 2 μM of (PhSe)2 or vehicle (control) for 48 h and then exposed to (C) 40 μM, (D) 70 μM, and (E) 100 μM tert-BuOOH. (F) MitoSOX assay
was recorded after 4 h of tert-BuOOH exposure. Data are represented as mean± SEM (n=5) * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 indicate the
statistical differences compared to the control group (white bar), #p < 0.001 indicate the differences between (PhSe)2 and control group that were exposed to tert-
BuOOH (black bar). One-way (B), Student's t-test (F) or two-way (C-E) ANOVA followed by the Tukey post hoc test were realized.
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40, 70, 100, 200, 400 and 600 μM). Because the glutathione-dependent
antioxidant system plays a key role in tert-BuOOH detoxification, we
investigated whether this system, particularly GPx activity, GSH levels,
Gpx isoforms and Gclc gene expression, could be modulated by (PhSe)2.
We found a time-response effect of (PhSe)2 on its ability to increase the
GPx activity (Fig. 5B), reaching a significant increase after 48 h of
(PhSe)2 incubation (around 6–8 fold increase – Fig. 5C). In order to
investigate if the (PhSe)2-induced increase in the GPx activity and GSH
levels was correlated with the enzyme gene expression of Gpx1, Gpx4,
and Gclc, the quantitative PCR analyses of gene expression at 30 h were
performed. Our results show a significant increase in the Gpx1 ex-
pression after 30 h of (PhSe)2 incubation (around 4 fold increase –
Fig. 5D). The copies number of cGpx4 and mtGpx4 transcripts were not
upregulated by (PhSe)2 (Fig. 5E-F). Regarding GSH modulation, the
results show that (PhSe)2 caused a significant increase in the GSH
(86.2%) and NPSH (62.5%) levels (Fig. 5H-I) that was accompanied by
a marked increase (2.3-fold) in the expression of Gclc, whose encoded
glutamate-cysteine ligase, the rate-limiting enzyme in glutathione bio-
synthesis (Fig. 5G).
3.6. Protective effect of (PhSe)2 depends on the GPx activity modulation
To understand the role of GPx on the protective effect of (PhSe)2
against tert-BuOOH-induced toxicity in HT22 cells, we performed an
experimental approach using mercaptosuccinic acid (MS), a specific
and potent inhibitor of GPx enzyme [36]. HT22 cells were pre-in-
cubated with (PhSe)2 (2 μM) in the presence or absence of MS (5mM)
followed by exposure to tert-BuOOH (40, 70 and 100 μM). We first
showed that MS caused a significant inhibition (about 50%) in the GPx
activity in (PhSe)2-pre-incubated cells (Fig. 6A). In addition, the
treatment of the cells with MS (5mM) significantly decreased the
protective effect of (PhSe)2 against tert-BuOOH-induced toxicity in
HT22 cells (Fig. 6B). This event was more evident when HT22 cells
were exposed to high concentration of tert-BuOOH used in this study
(100 μM) (Fig. 6B). The data show that GPx activity upregulation is
involved in the protection of (PhSe)2 against tert-BuOOH-induced
toxicity in HT22 cells.
3.7. Time course expression profiles of antioxidant genes modulated by
(PhSe)2
To analyze the involvement of Nrf-2 and FoxO-3 transcriptional
factors in (PhSe)2 cytoprotective actions, we performed a quantitative
PCR analyses of temporal expression (up to 24 h) of some target genes
of these transcriptional factors. Our results show an early (3 h) and
intense increase in heme oxygenase-1 (HO-1) expression, a sensitive
marker of Nrf-2 activation (Fig. 7C). Other selective genes trigged
through Nrf-2 were also improved by the pre-incubation with (PhSe)2.
Fig. 7(D and E) show a time-dependent increase in catalase (Cat) and
Gclc gene expression after (PhSe)2 incubation. The FoxO-3-regulated
genes (Fig. F-J), superoxide dismutase-2 (Sod2), thioredoxin reductase
2 (Txnrd2), and peroxiredoxins isoforms (Prdx2, Prdx3 and Prdx5) were
not modulated by (PhSe)2 in HT22 cells. According to the data of
Fig. 7A, (PhSe)2 also caused a substantial increase throughout the
glutathione antioxidant system and here we observed a sustained and
time-dependent increase in Gpx1 gene expression by (PhSe)2. However,
the relative expression of mtGpx4 was not modulated up to 24 h
(Fig. 7B).
4. Discussion
Neuronal cells are particularly vulnerable to oxidative stress be-
cause of its high metabolic rate and relatively low antioxidant defense
capability [3]. In these cells, lipid peroxidation, which is stimulated by
increased levels of peroxides, can significantly disrupt cellular function
and therefore lead to death [4]. Particularly in the brain, enzymes of
the GPx family, in association with other peroxidases, orchestrate an
adaptive response to oxidative stress by directly reducing peroxides,
favoring neuronal survival [5,33]. In this scenario, a significant effort
has been done to develop molecules that mimic the peroxidase activity
of the GPx, such as synthetic organoselenium compounds [38]. Among
these compounds, (PhSe)2, a diselenide GPx mimetic, has shown sig-
nificant beneficial effects in several models of oxidative stress-related
pathologies (for a review, see Nogueira and Rocha [34]. Here, we
propose (PhSe)2 as a promising therapeutic approach to prevent the
neuronal damage related to oxidative stress. Our results showed that
the potent cytoprotective action of (PhSe)2 in preventing the mi-
tochondrial dysfunction and oxidative stress promoted by tert-BuOOH
was due to an induction of an adaptive cellular antioxidant response.
Fig. 4. (PhSe)2 prevents the mitochondrial dysfunction induced by tert-BuOOH
(A) Representative respirometry assay of intact HT22 cells pre-incubated with
2 μM (PhSe)2 for 48 h followed the exposure or not with tert-BuOOH (40 μM)
for additional 4 h. After OCR stabilization, the following electron transport
system (ETS) modulators were added: Oligomycin (1.25 μM) to measure un-
coupled respiration; sequential additions (0.5 μM) of FCCP to achieve maximum
respiration; and antimycin A (2.5 μM) to determine residual oxygen consump-
tion rates. OCR records and mitochondrial reserve capacity of HT22 cells ex-
posed or not with tert-BuOOH (40 μM) for 2 h (B) and 4 h (C) were evaluated in
DMEM-5% FBS in the following conditions: basal respiration; after inhibition of
ATP synthase with oligomycin (uncoupled respiration – Uncoup.); upon titra-
tion with FCCP (maximum respiration – Max); and after inhibition of the re-
spiratory complex III with antimycin A (residual respiration – Rox). Data are
represented as mean ± SEM (n=4) * p < 0.05; ** p < 0.01; *** p < 0.001
and **** p < 0.0001 indicate statistical differences compared to the control
group (white bar). Two-way ANOVA followed by the Tukey post hoc test was
realized.
R.L. Quispe et al. Redox Biology 20 (2019) 118–129
124
There are several studies reporting that (PhSe)2 increases GPx ac-
tivity in the biological systems. In particular, some of these studies
[12,35] have linked such increase with neuroprotective effects. How-
ever, most of the current literature on this theme is composed of either
(i) phenomenological studies that only describe higher GPx activity
[36] or (ii) studies that show or hypothesize that the observed higher
GPx activity represents the consequence of the compound's thiol-per-
oxidase activity [35]. Here, we reported a mechanism for the neuro-
protective effect of (PhSe)2 that goes far beyond its known GPx mimetic
activity. Herein, we reported that (PhSe)2 was able to increase GPx by
stimulating the mRNA expression of GPx1 (but not GPx4). Of note,
experiments with mercaptosuccinic acid (GPx inhibitor) showed that
the observed increase in GPx activity was necessary for the observed
protection of (PhSe)2 against tert-BuOOH. In addition, (PhSe)2 also
caused a significant increase in GSH levels, which were paralleled by an
increase in Gclc expression. These results shed light into novel me-
chanisms concerning the antioxidant effects of this compound.
Oxidative stress and mitochondrial dysfunction have been reported
as critical factors in the pathophysiology of neurodegenerative diseases
[1,37]. Although, the oxidants production is part of cellular home-
ostasis, their overproduction cause mitochondrial dysfunction that can
culminate in energetic impairment and cell death [38,39]. According to
previous studies [40–42], here we observed an intense production of
oxidants induced by tert-BuOOH exposure in HT22 cells from the first
minutes of exposure (Fig. 3) that promoted mitochondria dysfunction
culminating later in cell death. By contrast, the pre-incubation of cells
with a nontoxic concentration of (PhSe)2 rendered cells more efficient
in detoxifying tert-BuOOH (or derived oxidants), which in turn pre-
vented the cell death, showing that these cells can cope better with pro-
oxidant situations. This in vitro observation can better explain the
neuroprotective effect of (PhSe)2 previously described in in vivo models
of neurodegenerative diseases, such as Alzheimer disease (AD) [11] and
neurotoxicity (CdCl2, H2O2, methimazole, and ischemia/reperfusion)
[43–46].
Mitochondria are also critical regulators of cell death [47,48].
Many lines of evidence suggest that mitochondrial dysfunction occurs
early and acts causally in neurodegenerative disease pathogenesis [1].
Therefore, protection of mitochondrial integrity and function is
Fig. 5. (PhSe)2 modulates the glutathione-dependent antioxidant system in HT22 cells. HT22 cells were pre-incubated with 2 μM (PhSe)2 for 48 h followed exposure
to tert-BuOOH concentrations (20–100 µM) (A). HT22 cells were treated with 2 μM (PhSe)2 for 48 h to determination of GPx activity (B-C), GSH content (H), and
NPSH content (I). Moreover, Gpx isoforms (D, E and F) and Gclc (G) gene expression was evaluated after 30 h of incubation with 2 μM (PhSe)2. Cellular GPx activity is
expressed as nmol NADPH consumed per minute per mg of protein. Transcripts levels of genes were normalized with β-actin gene and calculated by the 2−ΔΔCT
method. Copies number of Gpx4 transcripts of mitochondrial and cytosolic Gpx4 isoforms were calculated in relation of number copies of Gapdh using standard curve
of plasmids containing these genes. Values are represented as the mean ± SEM (A; n= 4, B-C; n=6, D-G, n= 4; H, n= 4, I; n=3). * p < 0.05; ** p < 0.01;
*** p < 0.001 and **** p < 0.0001 indicate statistical difference from control group (Student's t-test).
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emerging as a promising strategy to prevent neuronal damage. As
expected, the intense oxidants production induced by tert-BuOOH
caused a fast and significant impact on mitochondrial function in
HT22 cells. Decreases in the maximum OCR and mitochondrial reserve
capacity were observed as early as 2 h of exposure to tert-BuOOH
(40 µM) (Fig. 4B), therefore before the induction of cell death (which
occur in 12 h – Fig. 1C). A slightly longer exposure to tert-BuOOH
(4 h) further impaired the mitochondrial function by reducing the
basal OCR, the ATP-linked oxygen consumption, the maximum OCR
and mitochondrial reserve capacity (Fig. 4C). The excessive amount of
oxidants produced by tert-BuOOH would leads to oxidation of mi-
tochondrial proteins resulting in mitochondrial dysfunction, bioener-
getic impairment and exponential production of oxidants. In fact, the
decrease in mitochondrial reserve capacity has been described as a
strong indicator of mitochondrial dysfunction [49]. Similarly, a loss of
mitochondrial reserve capacity was observed in photoreceptor cells
exposed to tert-BuOOH [50]. Interestingly, our results indicate that
the pre-incubation with (PhSe)2 was efficient in preventing mi-
tochondrial dysfunction induced by tert-BuOOH probably by neu-
tralizing this peroxide or derived oxidants. In agreement with these
data, previous studies from our group has demonstrated that (PhSe)2
improve the mitochondrial reserve capacity and therefore prevented
oxidant-induced mitochondrial dysfunction in endothelial cells
[15,51]. Although, our results showed that (PhSe)2 protects HT22
cells from tert-BuOOH-induced mitochondrial dysfunction, we did not
observed its ability in increase mitochondrial reserve capacity (Fig. 4).
Together, these findings reinforce the idea that (PhSe)2 can maintain
the mitochondrial function in oxidative stress conditions, thus pre-
serving the bioenergetic and functional integrity of mitochondria in
HT22 neuronal cells exposed to tert-BuOOH.
Recent studies postulate that the antioxidant property of (PhSe)2
goes far beyond its mimic action to the GPx [14,51]. In fact, the pro-
tective action of (PhSe)2 was observed at a low concentration (2 µM)
and time-dependent, discarding an exclusive scavenger effect linked to
its peroxidatic activity. Additionally, it is important to consider that the
simple thiol-peroxidase activity of (PhSe)2, is approximately 3–4 order
lower than that of native GPxs ([18], seem to be not enough to justify
its well-reported antioxidant properties in biological systems [17].
Based on our first results (Figs. 1–3), we hypothesized that the effect of
(PhSe)2 in preserving mitochondrial function and cell survival could be
due to the increase in cellular antioxidant defenses. Our results showed
that (PhSe)2 positively modified the glutathione-dependent antioxidant
system in HT22 cells by increasing the Gpx1 gene expression and the
GPx activity, as well as the level of its co-substrate GSH, through the
increase in the expression of Gclc (a gene encoding γ-glutamylcysteine
synthetase, which is the limiting enzyme in the GSH pathway) (Fig. 5).
This fast and efficient cellular antioxidant modulation mediated by
(PhSe)2 made these cells more resistant to oxidative damage. It is
known that GSH is part of the glutathione peroxidase system, as an
electron donor that reacts directly with free radicals [52] and its re-
duction has been associated with a loss of the brain antioxidant defense
in neurodegenerative conditions [53]. In this context, compounds that
may induce an increase or renewal of GSH levels are of great relevance
in future therapies for neurodegenerative diseases.
Studies on the antioxidant effect of (PhSe)2 toward tert-butyl hy-
droperoxide are available in the literature. In fact, Ibrahim and col-
leagues [54–56] reported the antioxidant effects of some organosele-
nium compounds, including (PhSe)2 (used as a prototypal compound).
The authors showed that although (PhSe)2 did not present DPPH radical
scavenger activity, the organoselenium compounds were efficient in
reducing in vitro oxidative stress markers in brain homogenates and
attributed this effect to their GPx-like activity. It is important to men-
tion that they evaluated the thiol-peroxidase activity in an exclusive
chemical system. Therefore, the GPx-like activity was evaluated in
absence of viable cells or more complex biological samples, which made
impossible the occurrence of events such as transcription and/or
translation. Those studies and others are relevant to determine the
potency of organoselenium compounds regarding its chemical property
to reduce peroxides. Moreover, we previously evaluated the kinetic
reaction between (PhSe)2 and peroxynitrite in a stopped flow spectro-
photometer and we found that they did not react at an appreciable rate
(k2< 104 M−1 s−1) [14]. In addition, the direct oxidation of the se-
lenium atom of organic selenides by peroxides seems to occur only
when peroxides are present at the milimolar concentrations [57], which
have no biological relevance under our experimental conditions. The
results of the present study (especially Figs. 6 and 7) strongly suggest
that we evaluated the enzyme activity (with no interference of the
compound's GPx-like activity), considering the low concentrations of
(PhSe)2 used in our experiments (low micromolar). The increased levels
of GPx1 mRNA levels reinforce this idea.
To evaluate the contribution of GPx activity on the cytoprotective
effect of (PhSe)2, we exposed (PhSe)2-pre-incubated HT22 cells to MS,
an inhibitor of the GPx enzyme, slightly before tert-BuOOH exposure.
Our results showed that the MS decrease the effect of (PhSe)2 in pro-
tecting HT22 cells against cell death induced by exposure to different
concentrations of tert-BuOOH. Therefore, our results indicate that the
Fig. 6. The inhibition of GPx activity by MS
reverses the cytoprotective effect of (PhSe)2.
(A) GPx activity was evaluated in HT22 cells
pre-incubated with (PhSe)2 (2 μM) for 43 h
followed by incubation with mercaptosuccinic
acid (MS) (5mM, GPx inhibitor) for ~12 h.
Results are shown as mean ± SEM (n=3).
* p < 0.0001 indicate statistical difference
from control group (white bar) and
#p < 0.0001 indicate statistical difference
from (PhSe)2 group without MS (two-way
ANOVA followed by the Tukey post hoc test).
(B) HT22 cells were pre-incubated with
(PhSe)2 for 48 h and exposed to tert-BuOOH
(40, 70 and 100 μM) for 12 h, in the presence
or absence of MS (5mM). Cell viability was
evaluated by MTT reduction. Results are
shown as mean± SEM (n=5). * p < 0.0001
indicate statistical difference from control
group (white bar) and #p < 0.0001 indicate
statistical difference between (PhSe)2 in the
presence or not of MS (three-way ANOVA fol-
lowed by the Tukey post hoc test). The data
were compared with their respective controls (white bar) for each tert-BuOOH concentration.
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positive modulation of Gpx1 expression would be a key component for
the protection afforded by (PhSe)2 in HT22 cells. It should be men-
tioned the importance of GPx activity, since its decrease promote sus-
ceptibility to oxidative stress by allowing the accumulation of harmful
oxidants [58,59], and because other selenoproteins cannot replace its
function in protecting from generalized oxidative stress [5]. Gpx4 gene
expression was not upregulated after (PhSe)2 incubation and the results
of decrease observed in the mtGpx4 expression would not represent a
biological significance event according to functional thresholds used in
quantitative PCR analyses [60]. We can suppose that Gpx1 isoform
would be preferentially synthetized in (PhSe)2-treated HT22 cells,
suggesting an interplay between the different isoforms and also suggest
that (PhSe)2 regulates Gpx1-specific transcriptional machinery in HT22
cells that does not involve Gpx4. Contrary to our results, (PhSe)2 did not
increase the GPx activity and protein expression in neuroblastoma cells
[61], indicating that these cells would present a different physiological
response than those found in HT22 cells. Together these evidences re-
inforce the idea that this simple organoselenium compound acts as an
indirect and effective antioxidant by modulating intracellular redox-
sensitive responses.
Our results disclose that the molecular mechanism of neuroprotec-
tive actions of (PhSe)2 involves, at least in part, the GPx1 modulation,
Fig. 7. Time course expression profile of antioxidant genes modulated by (PhSe)2. HT22 cells were pre-incubated with 2 μM (PhSe)2 at different times (3 h, 6 h, 12 h
and 24 h) and gene expression was quantified. Transcripts levels of Gpx1 (A), mtGpx4 (B), HO-1 (C), Gclc (D), Cat (E), Prdx isoforms (F, G and H), Sod2 (I) and Txndr2
(J) were normalized with β-actin gene and calculated by the 2−ΔΔCT method. Values are represented as mean ± SEM (A-J; n=4). * p < 0.05 and ** p < 0.01
indicate statistical difference from control group (Student's t-test).
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however we can not discard the contribution of other antioxidant en-
zymes in its effects. In an in vivo study, our group showed that (PhSe)2
protected against methylmercury (MeHg)-induced mitochondrial
changes in the cerebral cortex of mice [62]. In the same study, we
observed that (PhSe)2 increased HO-1 content in cultured astroglial
cells (C6 lineage). In that study, the achieved results (mainly those
related to HO-1 expression) leaded us to hypothesize that (PhSe)2
would trigger the cytoprotective Nrf-2 pathway, although no evidence-
based results were provided [62]. According, some lines of evidence
propose that the “thiol modifier effects” of organoselenium compounds
might be more relevant for the explanation of their pharmacological
effects than their GPx-like activity [17]. Based on the fact that dis-
elenides are weak electrophiles, it is suggested that they can oxidize
critical cysteinyl residues in Keap1, allowing Nrf-2 to transcriptionally
activate the expression of antioxidant enzymes [14,17], such as HO-1,
which is a sensitive marker of the activation of Keap1/Nrf-2 signaling
pathway. In order to delve into this topic, here we evaluated some Nrf-
2-target genes in HT22 cells after (PhSe)2 treatment. The results (Fig. 7)
showed an early increase in HO-1 gene expression promoted by (PhSe)2
treatment. Notably, additional Nrf-2-target genes were also positively
modulated by (PhSe)2, such as Gclc (encoding the rate-limiting enzyme
in glutathione biosynthesis) and Cat (long-lasting effect). According, we
previously showed that (PhSe)2 induced redox regulation and nuclear
localization of Nrf-2 in endothelial cells [14]. Some evidence suggests
that GPx1 transcription may be regulated directly or indirectly by Nrf-2.
The expression of GPx1 was downregulated in lung after exposure to
cigarette smoke in Nrf-2-knockout mice [63], while, the enhanced Nrf-2
expression increased GPx1 transcription and decreased oxidants gen-
eration in glioma stem cells [64]. These results reinforce the idea that
(PhSe)2 triggers the cytoprotective Nrf-2 pathway.
Similarly to Nrf-2, FoxO-3 (forkhead box, class O-3) is also a redox-
regulated transcription factor involved in the control of stress-mediated
cellular responses. Of note, there is emerging evidence to the link be-
tween FoxO/Nrf-2 activation [65]. Some studies also support the par-
ticipation of FoxO-3 in GPx1 modulation. In chondrocytes, the con-
stitutive active form of FoxO-3 induced GPx1 while increasing cell
viability in response to tert-BuOOH [66]. Beside, the expression of
GPx1 was downregulated in FoxO-3-deficient erythroid precursor cells
[67]. Herein, the genic expression of some FoxO-3-regulated anti-
oxidant enzymes were analyzed. Only Gpx1 and Cat, which would be
trigged by either Nrf-2 or FoxO-3, were upregulated by (PhSe)2, while
Sod2, Txnrd2, Prdx3 and Prdx5, classically regulated by FoxO-3, were
not modulated by this organoselenium compound. We have previously
shown that (PhSe)2 increased the expression of Prdx3 and Sod2 [15]
and improved mitochondrial function in endothelial cells [51], sug-
gesting the involvement of FoxO-3 activation. In this sense, the con-
tribution of FoxO-3 pathway in the protective actions of (PhSe)2 in
HT22 cells should not be completely ruled out. Therefore, it is likely
that the Nrf-2 and/or FoxO-dependent signaling cascade(s) would be
trigged by (PhSe)2 through its “thiol modifier effects”, and these re-
sponses would depend of the cellular type.
In conclusion, we propose in the graphical abstract some molecular
mechanisms activated by (PhSe)2 in HT22 cells that allow the protec-
tion against the oxidative stress induced by tert-BuOOH. Our results
demonstrated that (PhSe)2 orchestrated an adaptive cellular response to
oxidative stress through Gpx1 modulation, which allowed cells to
neutralize oxidants and, as consequence, prevent mitochondrial dys-
function and cell death. This study shows that the cytoprotective effects
of (PhSe)2 goes far beyond its well-known thiol-peroxidase activity. In
contrast with the findings obtained in simple chemical systems, where
organoselenium compounds exhibits thiol-peroxidase-like activity, in
the complex scenario of living neuronal cells, (PhSe)2 has indirect GPx-
like activity. Importantly, in view of the superior efficiency of native
GPx enzymes over simple organoselenium compounds, the thiol
modifiers properties of (PhSe)2 and analogs have to be exploited in the
searching for effective antioxidant therapeutic agents.
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